Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Jost

Showing results (331-340 of 384) with videos related to

Pageof 39
Sort By:
Journal of Parkinson'S Disease|October 26, 2020
A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES TrialGiovanni Abbruzzese, Jaime Kulisevsky, Bruno Bergmans, et al.
Plos One|August 8, 2019
Evaluating health facility access using Bayesian spatial models and location analysis methodsNicholas J Tierney, Antonietta Mira, H Jost Reinhold, et al.
Journal of Neurology|January 3, 2025
Diagnosis and treatment of autonomic failure, pain and sleep disturbances in Parkinson's disease: guideline "Parkinson's disease" of the German Society of NeurologyAlessandra Fanciulli, Friederike Sixel-Döring, Carsten Buhmann, et al.
Parkinsonism & Related Disorders|April 10, 2025
Amygdala neurodegeneration differentiates brain-first and body-first Parkinson's disease: An MRI studyNils Schröter, Laura Matinpalo, Jonas A Hosp, et al.
Therapeutic Advances in Neurological Disorders|June 23, 2025
Insights into retention and safety/tolerability of apomorphine sublingual film in patients with Parkinson's disease and OFF episodes: post hoc analyses of a phase III, open-label studyJan Kassubek, Diego Santos Garcia, Wolfgang H Jost, et al.
Neurologia I Neurochirurgia Polska|January 12, 2021
Spasticity in practice (SPACE): an international non-interventional study of botulinum neurotoxin type A in treatment-naïve subjects with spasticityJulian Harriss, Nicolas Roche, Carlos Cantú-Brito, et al.
Clinical Neuroradiology|January 30, 2024
Complemental Value of Microstructural and Macrostructural MRI in the Discrimination of Neurodegenerative Parkinson SyndromesNils Schröter, Philipp G Arnold, Jonas A Hosp, et al.
The Journal of Nervous and Mental Disease|January 1, 2013
Reduced body mass index in Parkinson's disease: contribution of comorbid depressionMaximilian Pilhatsch, Nils B Kroemer, Christine Schneider, et al.
Neuroimage. Reports|June 26, 2025
Domain-specific brain regions are associated with cognitive impairment in progressive supranuclear palsyN Schröter, M Rijntjes, J A Hosp, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 28, 2023
Cerebellar, Not Nigrostriatal Degeneration Impairs Dexterity in Multiple System AtrophyAlexander Rau, Jonas A Hosp, Michel Rijntjes, et al.
Pageof 39

Showing results (331-340 of 384) with videos related to

Sort By:
Pageof 39
Journal of Parkinson'S Disease|October 26, 2020
A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES TrialGiovanni Abbruzzese, Jaime Kulisevsky, Bruno Bergmans, et al.
Plos One|August 8, 2019
Evaluating health facility access using Bayesian spatial models and location analysis methodsNicholas J Tierney, Antonietta Mira, H Jost Reinhold, et al.
Journal of Neurology|January 3, 2025
Diagnosis and treatment of autonomic failure, pain and sleep disturbances in Parkinson's disease: guideline "Parkinson's disease" of the German Society of NeurologyAlessandra Fanciulli, Friederike Sixel-Döring, Carsten Buhmann, et al.
Parkinsonism & Related Disorders|April 10, 2025
Amygdala neurodegeneration differentiates brain-first and body-first Parkinson's disease: An MRI studyNils Schröter, Laura Matinpalo, Jonas A Hosp, et al.
Therapeutic Advances in Neurological Disorders|June 23, 2025
Insights into retention and safety/tolerability of apomorphine sublingual film in patients with Parkinson's disease and OFF episodes: post hoc analyses of a phase III, open-label studyJan Kassubek, Diego Santos Garcia, Wolfgang H Jost, et al.
Neurologia I Neurochirurgia Polska|January 12, 2021
Spasticity in practice (SPACE): an international non-interventional study of botulinum neurotoxin type A in treatment-naïve subjects with spasticityJulian Harriss, Nicolas Roche, Carlos Cantú-Brito, et al.
Clinical Neuroradiology|January 30, 2024
Complemental Value of Microstructural and Macrostructural MRI in the Discrimination of Neurodegenerative Parkinson SyndromesNils Schröter, Philipp G Arnold, Jonas A Hosp, et al.
The Journal of Nervous and Mental Disease|January 1, 2013
Reduced body mass index in Parkinson's disease: contribution of comorbid depressionMaximilian Pilhatsch, Nils B Kroemer, Christine Schneider, et al.
Neuroimage. Reports|June 26, 2025
Domain-specific brain regions are associated with cognitive impairment in progressive supranuclear palsyN Schröter, M Rijntjes, J A Hosp, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 28, 2023
Cerebellar, Not Nigrostriatal Degeneration Impairs Dexterity in Multiple System AtrophyAlexander Rau, Jonas A Hosp, Michel Rijntjes, et al.
Pageof 39